As of 2024-12-14, the EV/EBITDA ratio of Hutchison China MediTech Ltd (HCM.L) is -32.18. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. HCM.L's latest enterprise value is 2,078.79 mil GBP. HCM.L's TTM EBITDA according to its financial statements is -64.60 mil GBP. Dividing these 2 quantities gives us the above HCM.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 5.7x - 7.3x | 6.5x |
| Forward P/E multiples | 6.7x - 18.2x | 9.2x |
| Fair Price | (22.83) - (26.51) | (29.92) |
| Upside | -108.8% - -110.2% | -111.5% |
| Date | EV/EBITDA |
| 2024-12-10 | -32.89 |
| 2024-12-09 | -34.61 |
| 2024-12-06 | -34.09 |
| 2024-12-05 | -31.97 |
| 2024-12-04 | -33.29 |
| 2024-12-03 | -34.09 |
| 2024-12-02 | -34.22 |
| 2024-11-29 | -32.76 |
| 2024-11-28 | -33.82 |
| 2024-11-27 | -35.54 |
| 2024-11-26 | -33.69 |
| 2024-11-25 | -34.48 |
| 2024-11-22 | -33.95 |
| 2024-11-21 | -34.35 |
| 2024-11-20 | -34.75 |
| 2024-11-19 | -31.57 |
| 2024-11-18 | -32.23 |
| 2024-11-15 | -32.10 |
| 2024-11-14 | -32.23 |
| 2024-11-13 | -32.63 |
| 2024-11-12 | -33.69 |
| 2024-11-11 | -33.69 |
| 2024-11-08 | -33.56 |
| 2024-11-07 | -34.75 |
| 2024-11-06 | -34.75 |
| 2024-11-05 | -35.01 |
| 2024-11-04 | -35.28 |
| 2024-11-01 | -35.28 |
| 2024-10-31 | -35.01 |
| 2024-10-30 | -35.81 |
| 2024-10-29 | -37.53 |
| 2024-10-28 | -39.11 |
| 2024-10-25 | -39.91 |
| 2024-10-24 | -38.85 |
| 2024-10-23 | -40.17 |
| 2024-10-22 | -40.17 |
| 2024-10-21 | -38.98 |
| 2024-10-18 | -38.45 |
| 2024-10-17 | -36.20 |
| 2024-10-16 | -37.26 |
| 2024-10-15 | -34.75 |
| 2024-10-14 | -35.94 |
| 2024-10-11 | -35.81 |
| 2024-10-10 | -36.86 |
| 2024-10-09 | -36.86 |
| 2024-10-08 | -38.19 |
| 2024-10-07 | -38.45 |
| 2024-10-04 | -38.19 |
| 2024-10-03 | -36.60 |
| 2024-10-02 | -37.66 |